Inpharmatis SIA
Country headquarter:
Latvia.
Market presence:
Latvia, Lithuania, Estonia, Russian Federation, Ukraine, Belarus, Uzbekistan, Tadjikistan, Kazakhstan, Kyrgyzstan, Turkmenistan, Georgia, Armenia, Azerbaijan and Israel.
General description:
Inpharmatis offer comprehensive regulatory affairs services to Life Science Industry including Drug Development and Vigilance Services to pharmaceutical, medical device, food supplements, cosmetic and biotech companies As well we offer consulting services in regulatory operations, e.g. transition to electronic submission, submission process optimisation, implementation of efficient regulatory information management (RIM), Our area of expertise lies in the European & CIS market.
We offer more than 20 interactive professional development training courses for pharmaceutical industry, oriented to achieve both – individual and corporate needs of pharmaceutical industry.
Areas of regulatory/reimbursement support:
Full regulatory, life cycle and submission management, EU GMP licensing, GMP licensing, Pharmacovigilance services.
https://ec.europa.eu/digital-single-market/en/ehealth-and-ageing
The eHealth Hub project has received funding from the European Union’s Horizon 2020
Research and Innovation Programme under Grant Agreement No727683.